Determination of Entacapone by Differential Pulse Polarography in Pharmaceutical FormulationFootnote

We thank ORION PHARMA and NOVARTIS laboratories for donating the pure form studied here. We thank E. Agnès‐Legris, B. Ferré, D. Bigny, M. Dubois for their technical assistance.

References

• Darchen , A. and Peltier , D. 1972 . Nouvel examen des mécanismes de réduction électrochimique des p et o‐nitrophenols . Bull. Chem. Soc. Fr. , 1 : 401 – 404 .
   Google Scholar
• Holm , K. J. and Spencer , C. M. 1999 . Entacapone: A review of its use in Parkinson's disease . Drugs , 58 ( 1 ) : 159 – 177 .
   PubMed Web of Science ®Google Scholar
• Kaakkola , S. 2000 . Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease . Drugs , 59 ( 6 ) : 1233 – 1250 .
   PubMed Web of Science ®Google Scholar
• Karlsson , M. and Wikberg , T. 1992 . Liquid chromatographic determination of a new catechol‐O‐methyltransferase inhibitor, entacapone and its Z‐isomer in human plasma and urine . Journal of Pharmaceutical and Biomedical Analysis , 10 ( 8 ) : 593 – 600 .
   PubMedGoogle Scholar
• Keski‐Hynnila , H. , Raanaa , K. , Forsberg , M. , Mannisto , P. , Taskinen , J. and Kostiainen , R. 2001 . Quantitation of entacapone glucuronide in rat plasma by online coupled restricted access media column and liquid chromatography‐tandem mass spectrometry . Journal of Chromatography B, Biomedical Sciences and Applications , 759 ( 2 ) : 227 – 236 .
   PubMedGoogle Scholar
• Keski‐Hynnila , H. , Raanaa , K. , Taskinen , J. and Kostiainen , R. 2000 . Direct analysis of nitrocatechol‐type glucuronides in urine by capillary electrophoresis‐electrospray ionisation mass spectrometry and tandem mass spectrometry . Journal of Chromatography B, Biomedical Sciences and Applications , 749 ( 2 ) : 253 – 263 .
   PubMedGoogle Scholar
• Korlpara , L. V.P. , Cooper , J. M. and Anthony , H. V. 2004 . Differences in toxicity of the catechol‐O‐methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells . Neuropharmacology , 46 ( 4 ) : 562 – 569 .
   PubMedGoogle Scholar
• Lehtonen , P. , Lehtinen , S. , Malkki‐Laine , L. and Wikberg , T. 1999 . Micellar electrokinetic capillary chromatography method for direct determination of glucuronides of entacapone and its (Z)‐isomer in human urine . Journal of Chromatography A , 836 ( 1 ) : 173 – 188 .
   PubMedGoogle Scholar
• Lehtonen , P. , Malkki‐Laine , L. and Wikberg , T. 1999 . Separation of the glucuronides of entacapone and its (Z)‐isomer in urine by micellar electrokinetic capillary chromatography . Journal of Chromatography B, Biomedical Sciences and Applications , 721 ( 1 ) : 127 – 134 .
   PubMedGoogle Scholar
• Mannisto , P. T. and Kaakkola , S. 1999 . Catechol‐O‐methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors . Pharmacological Reviews , 51 ( 4 ) : 593 – 628 .
   PubMed Web of Science ®Google Scholar
• Orama , M. , Tilus , P. , Taskinen , J. and Lotta , T. 1997 . Iron(III)‐chelating properties of the novel catechol‐O‐methyltransferase inhibitor entacapone in aqueous solution . Journal of Pharmaceutical Sciences , 86 ( 7 ) : 827 – 831 .
   PubMedGoogle Scholar
• Paim , C. S. , Goncalves , H. M.L. , Miron , D. , Sippel , J. and Steppe , M. 2007 . Stability‐indication LC determination of entacapone in tablets . Chromatographia , 65 ( 9/10 ) : 595 – 599 .
   Google Scholar
• Perez , R. A. , Fernandez‐Alvarez , E. , Nieto , O. and Piedrafita , F. J. 1993 . Inhibition of catechol‐O‐methyltransferase by 1‐vinyl derivatives of nitrocatechols and nitroguaiacols . Biochemical Pharmacology , 45 ( 10 ) : 1973 – 1981 .
   PubMedGoogle Scholar
• Rajeswari , K. R. , Sankar , G. G. , Rao , A. L. and Rao , J. V.N.S. 2006 . A new spectrophotometric method for the determination of entacapone in pure and tablet dosage form . International Journal of Chemical Sciences , 4 ( 3 ) : 694 – 696 .
   Google Scholar
• Ramakrishna , N. V.S. , Vishwottam , K. N. , Wishu , S. , Koteshwara , M. and Chidambara , J. 2005 . High‐performance liquid chromatography method for the quantification of entacapone in human plasma . Journal of Chromatography B , 823 ( 2 ) : 189 – 194 .
   PubMedGoogle Scholar
• Smith , K. S. , Smith , P. L. , Heady , T. N. , Trugman , J. M. , Harman , W. D. and Macdonald , T. L. 2003 . In vitro metabolism of tolcapone to reactive intermediates: Relevance to tolcapone liver toxicity . Chemical Research in Toxicology , 16 : 123 – 128 .
   PubMed Web of Science ®Google Scholar
• Smyth , W. F. 1979 . Polarography of Molecules of Biological Significance 111 Londres : Academic Press .
   Google Scholar
• Technical documentation Comtan® . 1999 . Novartis Laboratory .
   Google Scholar
• Wikberg , T. , Vuorela , A. , Ottoila , P. and Taskinen , J. 1993 . Identification of major metabolites of the catechol‐O‐methyltransferase inhibitor entacapone in rats and humans . Drug Metabolism and disposition , 21 ( 1 ) : 81 – 92 .
   PubMed Web of Science ®Google Scholar